Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. The company is headquartered in Bunkyo-Ku, Tokyo-To and currently employs 13,506 full-time employees. The firm operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The firm is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Eisai Co., Ltd. tiene un dividendo anual de 0.27 por acción, con un rendimiento del 0.00%. El dividendo se paga semestralmente y la última fecha ex-dividendo fue Sep 29, 2025.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.00%
$0.27
Sep 29, 2025
Frecuencia de pago
Relación de pago
Semestralmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Sep 29, 2025
$80.00
Sep 30, 2025
Nov 18, 2025
Mar 28, 2025
$80.00
Mar 31, 2025
May 30, 2025
Sep 27, 2024
$80.00
Sep 30, 2024
Nov 19, 2024
Mar 28, 2024
$80.00
Mar 31, 2024
May 29, 2024
Sep 28, 2023
$80.00
Sep 30, 2023
Nov 17, 2023
Mar 30, 2023
$80.00
Mar 31, 2023
May 29, 2023
Gráficos de dividendos
ESAIY Dividendos
ESAIY Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Eisai Co., Ltd. y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Eisai Co., Ltd.?